Canaccord Genuity Maintains Hold on HealthStream, Raises Price Target to $24

Benzinga Newsdesk www.benzinga.com Positive 56.9%

Neg 0% Neu 0% Pos 56.9%

Canaccord Genuity analyst Richard Close maintains HealthStream (NASDAQ:HSTM) with a Hold and raises the price target from $21 to $24.